Enrollment for a randomized phase 2 trial designed to compare a triplet regimen and doublet regimen for certain patients with leukemia has been discontinued due to low likelihood of benefit. The ...
Results presented today at the ESMO Congress 2019, Barcelona 27 September - 01 October, during the second Proffered Paper Session on Gastrointestinal tumors (colorectal) by VHIO's Director, Josep ...
ORLANDO, Florida — A new triplet therapy, comprising carfilzomib (Kyprolis, Amgen), dexamethasone, and daratumumab (Darzalex, Amgen), known as KdD, should become a new standard of care in the ...
WEST BRIDGEWATER – For families with multiple children, life can sometimes be hectic and stressful. At this annual holiday celebration, everyone can relate. Keeping Pace with Multiple Miracles, a ...
MINNEAPOLIS, Oct. 18, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced detailed efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback